SCHEMBL4690799

SCHEMBL4690799

COc1cc2c(NC(=S)Nc3c(C)cccc3C)ncnc2cc1OCCCN1CCOCC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 12/20 0.64
KDR P35968 9/20 0.64
EGFR P00533 7/20 0.63
BRAF P15056 1/20 0.63
RET P07949 2/20 0.62
KIF5B P33176 1/20 0.62
AURKA O14965 2/20 0.60
ROCK2 O75116 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LCK P06239 1/20 0.60
FYN P06241 1/20 0.60
MET P08581 1/20 0.60
MAPT P10636 1/20 0.60
PDGFRA P16234 1/20 0.60
LTK P29376 1/20 0.60
TTK P33981 1/20 0.60
MAP2K2 P36507 1/20 0.60
MAP2K1 Q02750 1/20 0.60
BTK Q06187 1/20 0.60
TYRO3 Q06418 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4689817 1.00 SRC (0.64) SRCKDREGFRBRAFRET
SCHEMBL4693023 0.96 RET (0.61) SRCKDREGFRBRAFRET
SCHEMBL4686384 0.91 KDR (0.61) SRCKDREGFRRETLCK
SCHEMBL4689828 0.88 RET (0.60) KDREGFRRETKIF5B
SCHEMBL4687659 0.87 SRC (0.58) SRCKDREGFRRETKIF5B
SCHEMBL4687883 0.87 EGFR (0.65) SRCKDREGFRRETAURKA
SCHEMBL4686900 0.87 KDR (0.65) SRCKDREGFRRET
SCHEMBL4687801 0.83 RET (0.66) SRCKDREGFRRETKIF5B
SCHEMBL5828725 0.83 FLT1 (0.62) SRCKDREGFRBRAFRET
SCHEMBL5832489 0.83 FLT1 (0.62) SRCKDREGFRBRAFRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed